Endogenous interferon alpha synthesis pathway (IFN-alpha synthesis pathway)

The endogenous interferon alpha (IFN-α) synthesis pathway is a critical component of the innate immune system responsible for producing Type I interferons in response to viral and bacterial pathogens (Source: PubMed, PMID: 21824864). This pathway is primarily initiated by the activation of pattern recognition receptors (PRRs), such as Toll-like receptors (TLR7, TLR8, and TLR9) in plasmacytoid dendritic cells, or cytosolic sensors like cGAS-STING (Source: NIH, Toll-like Receptors). Upon activation, these sensors trigger a signaling cascade involving adapter proteins like MyD88, leading to the phosphorylation and nuclear translocation of interferon regulatory factors, particularly IRF7 (Source: UniProt, P35944). Once in the nucleus, IRF7 induces the transcription of multiple IFN-α subtypes, which are then secreted to initiate an antiviral state in neighboring cells (Source: Nature Reviews Immunology, doi:10.1038/nri.2017.111). In therapeutic contexts, this pathway is targeted by agonists like imiquimod to treat viral infections and certain cancers by boosting local IFN production (Source: PubChem, CID 3689). Conversely, overactivation of this pathway is a hallmark of autoimmune diseases such as systemic lupus erythematosus (SLE), where chronic IFN-α production drives tissue damage (Source: Journal of Clinical Investigation, doi:10.1172/JCI124450).

Other names

Type I interferon production pathwayIFN-alpha induction pathwayTLR-mediated IFN-alpha synthesispDC interferon synthesis pathway

Agonists bind to Toll-like receptors (TLR7/8/9) to stimulate the MyD88-IRF7 signaling axis, while antagonists or inhibitors block these receptors or downstream signaling to prevent the transcription and secretion of interferon alpha.